For U.S. Healthcare Professionals Only

Visit Sanofi U.S.:

This bibliography contains links to literature and PubMed abstracts on topics related to Gaucher Disease, including diagnosis, treatment therapies, comorbidities, cancer incidence, and disease registry analyses.


Murugesan V, Chuang WL, Liu J, et al. Glucosylsphingosine is a key biomarker of Gaucher disease. Am J Hematol. 2016;91(11):1082-1089.
https://www.ncbi.nlm.nih.gov/pubmed/27441734


Mistry PK, Belmatoug N, Vom dahl S, Giugliani R. Understanding the natural history of Gaucher disease. Am J Hematol. 2015;90 Suppl 1:S6-11.
https://www.ncbi.nlm.nih.gov/pubmed/26096746


Rosenbloom B, Balwani M, Bronstein JM, et al. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol Dis. 2011;46(1):95-102.
https://www.ncbi.nlm.nih.gov/pubmed/21067946/


Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med. 2006;160(6):603-608.
https://www.ncbi.nlm.nih.gov/pubmed/16754822


Rosenbloom BE, Weinreb NJ, Zimran A, et al. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood. 2005;105(12):4569-4572.
https://www.ncbi.nlm.nih.gov/pubmed/15718419/


 

 

 

 

 

SGUSMA.XLSD.18.07.0421

Last Updated: Mar 7, 2019